Repligen Corp financial data

Symbol
RGEN on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
41 Seyon Street, Building 1, Suite 100, Waltham, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Jul 30, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 501 % +101%
Quick Ratio 91.8 % +51.3%
Debt-to-equity 39.6 % +25.4%
Return On Equity -0.1 % -101%
Return On Assets -0.07 % -101%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 56M shares +0.45%
Common Stock, Shares, Outstanding 55.9M shares +0.28%
Entity Public Float 6.93B USD -22.2%
Common Stock, Value, Issued 559K USD +0.36%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 42.7M USD -1.22%
Costs and Expenses 595M USD +3.07%
Operating Income (Loss) 7.44M USD -95.1%
Nonoperating Income (Expense) 2.74M USD -71.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 10.2M USD -93.7%
Income Tax Expense (Benefit) 12.1M USD -49%
Net Income (Loss) Attributable to Parent -1.9M USD -101%
Earnings Per Share, Basic -0.03 USD/shares -101%
Earnings Per Share, Diluted -0.02 USD/shares -101%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 809M USD +34%
Accounts Receivable, after Allowance for Credit Loss, Current 123M USD +2.45%
Inventory, Net 191M USD -20.9%
Other Assets, Current 13.3M USD +29.6%
Assets, Current 1.16B USD +16.1%
Deferred Income Tax Assets, Net 678K USD -61.4%
Property, Plant and Equipment, Net 205M USD +1.01%
Operating Lease, Right-of-Use Asset 131M USD +7.71%
Intangible Assets, Net (Excluding Goodwill) 380M USD +7.99%
Goodwill 986M USD +13.2%
Other Assets, Noncurrent 853K USD -48.7%
Assets 2.86B USD +12.3%
Accounts Payable, Current 20.9M USD -12.1%
Employee-related Liabilities, Current 23.4M USD +101%
Accrued Liabilities, Current 57.9M USD +28.5%
Liabilities, Current 174M USD -53.3%
Operating Lease, Liability, Noncurrent 144M USD +6.75%
Other Liabilities, Noncurrent 3.71M USD -4.51%
Liabilities 876M USD +51.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -44.2M USD -19%
Retained Earnings (Accumulated Deficit) 444M USD -0.43%
Stockholders' Equity Attributable to Parent 1.99B USD +0.78%
Liabilities and Equity 2.86B USD +12.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 44.7M USD +301%
Net Cash Provided by (Used in) Financing Activities -8.97M USD +6.16%
Net Cash Provided by (Used in) Investing Activities -8.36M USD +11.4%
Common Stock, Shares Authorized 80M shares 0%
Common Stock, Shares, Issued 55.9M shares +0.28%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 29.3M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 809M USD +34%
Deferred Tax Assets, Valuation Allowance 20K USD +5.26%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 81.1M USD +17.8%
Operating Lease, Liability 159M USD +15%
Depreciation 23.9M USD +45.7%
Payments to Acquire Property, Plant, and Equipment 8.35M USD -1.92%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -8.96M USD -106%
Lessee, Operating Lease, Liability, to be Paid 201M USD +10%
Property, Plant and Equipment, Gross 348M USD +11.7%
Operating Lease, Liability, Current 12.1M USD +320%
Lessee, Operating Lease, Liability, to be Paid, Year Two 25.6M USD +18.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 22.6M USD +13.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) -833K USD +25.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 32.6M USD +9.17%
Lessee, Operating Lease, Liability, to be Paid, Year Three 25.4M USD +17.8%
Deferred Tax Assets, Operating Loss Carryforwards 7.58M USD -22.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 3.14M USD +4.77%
Lessee, Operating Lease, Liability, to be Paid, Year Four 23.9M USD +12.1%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 33.3M USD +15.6%
Deferred Tax Assets, Net of Valuation Allowance 81.1M USD +17.8%
Interest Expense 11.3M USD +887%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%